Cancer is a global health problem and one of the leading causes of mortality. Immune checkpoint inhibitors have revolutionized the field of oncology, emerging as a powerful treatment strategy. A key pathway that has garnered considerable attention is pro
Home remedies, natural cures and information on causes, symptoms and diet conditions for common ailments and diseases. Also provides information on health benefits from common ingredients like honey, garlic, aloe vera and many others.
Its sulfate injection form was approved in the United States in 1963 for the treatment of acute lymphoblastic leukemia, lymphoma, and multiple myeloma [66]. The clinical use of both drugs is somewhat limited by their neurotoxicity. However, advances in chemical synthesis have led to the ...
Multiple myeloma. Well, I don't know most of the listed cancer disorders, anyways these two alkaloids are impressive. Herz the chemical structure of these two guyz. So, Rosy Periwinkle, you can't miss this plant. Look for it, and take your hats off to it ;-)) ...
prostate cancer (PC-3), melanoma (B16-F10, A375-S2), nasopharyngeal carcinoma (HONE1 and CNE1), glioblastoma (U87-MG, U87 and C6), urothelial cell carcinoma (5637 and HT1197), multiple myeloma (U266 and RPMI8226), cholangiocarcinoma (HuCCT-1 and TFK-1), cervical cancer (HeLa) cells...
Molecular biotechnology uses laboratory techniques to study and modify nucleic acids and proteins for applications in areas such as human and animal health, agriculture, and the environment. Herbal extracts are now widely used in the management of chronic diseases like diabetes, hypertension, cancer, ...
The adjusted hazard ratios for uterine, prostate, and thyroid cancers were 0.83, 1.22, and 1.54, respectively, indicating no significant increase in mortality from these cancers. However, a substantial increase in mortality was observed for lung cancer (aHR 3.72) and myeloma (aHR 4.42). Pre-...
Gliadel is a drug used for the treatment of cancer that works by interfering with the growth and spread of ...
As part of its mechanism of action, it acts like a CD38 inhibitor binding to myeloma cells and blocking growth or slowing spread. Before Sarclisa, one had to also take an FDA approved CD38 inhibitor such as daratumumab along with other treatments. This new drug is not a first line agent,...
This medication pronounced, x-po-vee-o comes as a 20mg pill and was approved in July 2019 to treat Multiple Myeloma, a blood cancer. The drug is intended to be used along with a corticosteroid (such as dexamethasone or prednisone). It’s actually not the first line agent, it’s more ...